U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588139) titled 'A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants' on May 08.
Brief Summary: The purpose of this study is to evaluate the interstitial concentrations using the open-flow microperfusion device and plasma pharmacokinetics following multiple doses of povorcitinib or topical ruxolitinib cream in healthy adult participants.
Study Start Date: May 18
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Povorcitinib
Oral; Tablet
DRUG: Ruxolitinib
Ruxolitinib cream applied topi...